138 related articles for article (PubMed ID: 29675543)
1. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
[TBL] [Abstract][Full Text] [Related]
2. Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine.
Han S; Ma W; Jiang D; Sutherlin L; Zhang J; Lu Y; Huo N; Chen Z; Engle JW; Wang Y; Xu X; Kang L; Cai W; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):394. PubMed ID: 34838057
[TBL] [Abstract][Full Text] [Related]
3. Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens.
Fan Y; Sahdev P; Ochyl LJ; Akerberg J; Moon JJ
J Control Release; 2015 Jun; 208():121-129. PubMed ID: 25869965
[TBL] [Abstract][Full Text] [Related]
4. A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA.
Carson CS; Becker KW; Garland KM; Pagendarm HM; Stone PT; Arora K; Wang-Bishop L; Baljon JJ; Cruz LD; Joyce S; Wilson JT
J Control Release; 2022 May; 345():354-370. PubMed ID: 35301055
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient
Ebrahimian M; Hashemi M; Maleki M; Hashemitabar G; Abnous K; Ramezani M; Haghparast A
Front Immunol; 2017; 8():1077. PubMed ID: 28955328
[TBL] [Abstract][Full Text] [Related]
6. Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo.
Luo L; Qin T; Huang Y; Zheng S; Bo R; Liu Z; Xing J; Hu Y; Liu J; Wang D
Drug Deliv; 2017 Nov; 24(1):1099-1111. PubMed ID: 28776443
[TBL] [Abstract][Full Text] [Related]
7. Multicomponent Pathogen-Mimicking Nanoparticles Induce Intestinal Immune Responses against Paratuberculosis.
Liu Y; Long M; Wang Y; Liang Z; Dong Y; Qu M; Ge X; Nan Y; Chen Y; Zhou X
ACS Biomater Sci Eng; 2024 May; 10(5):3387-3400. PubMed ID: 38656158
[TBL] [Abstract][Full Text] [Related]
8. Dual-Responsive Glycopolymers for Intracellular Codelivery of Antigen and Lipophilic Adjuvants.
De Mel J; Hossain M; Shofolawe-Bakare O; Mohammad SA; Rasmussen E; Milloy K; Shields M; Roth EW; Arora K; Cueto R; Tang SC; Wilson JT; Smith AE; Werfel TA
Mol Pharm; 2022 Dec; 19(12):4705-4716. PubMed ID: 36374992
[TBL] [Abstract][Full Text] [Related]
9. Antigen-Specific Stimulation of CD8
Hong E; Dobrovolskaia MA
Methods Mol Biol; 2024; 2789():171-184. PubMed ID: 38507003
[TBL] [Abstract][Full Text] [Related]
10. Immune cell receptor-specific nanoparticles as a potent adjuvant for nasal split influenza vaccine delivery.
Li X; Xiu X; Su R; Ma S; Li Z; Zhang L; Wang Z; Zhu Y; Ma F
Nanotechnology; 2024 Jan; 35(12):. PubMed ID: 38100843
[TBL] [Abstract][Full Text] [Related]
11. Probiotic-derived amphiphilic exopolysaccharide self-assembling adjuvant delivery platform for enhancing immune responses.
Sheng S; Zhang H; Li X; Chen J; Wang P; Liang Y; Li C; Li H; Pan N; Bao X; Liu M; Zhao L; Li X; Guan P; Wang X
J Nanobiotechnology; 2024 May; 22(1):267. PubMed ID: 38764014
[TBL] [Abstract][Full Text] [Related]
12. An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses.
Oyama R; Ishigame H; Tanaka H; Tateshita N; Itazawa M; Imai R; Nishiumi N; Kishikawa JI; Kato T; Anindita J; Nishikawa Y; Maeki M; Tokeshi M; Tange K; Nakai Y; Sakurai Y; Okada T; Akita H
ACS Nano; 2023 Oct; 17(19):18758-18774. PubMed ID: 37814788
[TBL] [Abstract][Full Text] [Related]
13. Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells After Treatment with Nanoparticles.
Hong E; Dobrovolskaia MA
Methods Mol Biol; 2024; 2789():161-169. PubMed ID: 38507002
[TBL] [Abstract][Full Text] [Related]
14. Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response.
Zhao M; He C; Zheng X; Jiang M; Xie Z; Wei H; Zhang S; Lin Y; Zhang J; Sun X
J Control Release; 2024 May; 369():556-572. PubMed ID: 38580136
[TBL] [Abstract][Full Text] [Related]
15. Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing.
Chang TZ; Stadmiller SS; Staskevicius E; Champion JA
Biomater Sci; 2017 Jan; 5(2):223-233. PubMed ID: 27918020
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice.
Islam MA; Rice J; Reesor E; Zope H; Tao W; Lim M; Ding J; Chen Y; Aduluso D; Zetter BR; Farokhzad OC; Shi J
Biomaterials; 2021 Jan; 266():120431. PubMed ID: 33099060
[TBL] [Abstract][Full Text] [Related]
17. Ovalbumin and Poly(i:c) Encapsulated Dendritic Cell-Targeted Nanoparticles for Immune Activation in the Small Intestinal Lymphatic System.
Kim KS; Lee S; Na K; Bae YH
Adv Healthc Mater; 2022 Nov; 11(21):e2200909. PubMed ID: 35835068
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable PLGA-
Wilson KL; Howard GP; Coatsworth H; Dinglasan RR; Mao HQ; Plebanski M
Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32485944
[TBL] [Abstract][Full Text] [Related]
19. Hybrid mRNA Nano Vaccine Potentiates Antigenic Peptide Presentation and Dendritic Cell Maturation for Effective Cancer Vaccine Therapy and Enhances Response to Immune Checkpoint Blockade.
Shi L; Yang J; Nie Y; Huang Y; Gu H
Adv Healthc Mater; 2023 Dec; 12(32):e2301261. PubMed ID: 37822133
[TBL] [Abstract][Full Text] [Related]
20. Activates B lymphocytes and enhanced immune response: A promising adjuvant based on PLGA nanoparticle to improve the sensitivity of ZEN monoclonal antibody.
Pang C; Yuan B; Ren K; Xu H; Nie K; Yu C; Liu Z; Zhang Y; Ozkan SA; Yang Q
Talanta; 2024 Jul; 274():126005. PubMed ID: 38599116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
